Search

everythinglearnresearchcommunity

for

Search:↓

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Sublingual minoxidil effectively treats hair loss with mild side effects.

Oral bicalutamide is safe and effective for female hair loss.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

COVID-19 doesn't make alopecia areata worse.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

The Trichoscopy Derived Sinclair Scale offers a more accurate and reliable way to measure hair loss severity than the traditional visual method.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Filaggrin mutations are linked to atopic dermatitis and help explain how genetics and environment affect the disease.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

The timing of when the gene Bmal1 is active affects aging and survival, with its absence during development, not adulthood, leading to premature aging.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.